These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19204064)

  • 1. NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD.
    Yan TC; McQuillin A; Thapar A; Asherson P; Hunt SP; Stanford SC; Gurling H
    J Psychopharmacol; 2010 Jan; 24(1):27-38. PubMed ID: 19204064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural and neurochemical abnormalities in mice lacking functional tachykinin-1 (NK1) receptors: a model of attention deficit hyperactivity disorder.
    Yan TC; Hunt SP; Stanford SC
    Neuropharmacology; 2009 Dec; 57(7-8):627-35. PubMed ID: 19748515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perseveration by NK1R-/- ('knockout') mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance Test.
    Pillidge K; Porter AJ; Young JW; Stanford SC
    J Psychopharmacol; 2016 Sep; 30(9):837-47. PubMed ID: 27097734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic association of the tachykinin receptor 1 TACR1 gene in bipolar disorder, attention deficit hyperactivity disorder, and the alcohol dependence syndrome.
    Sharp SI; McQuillin A; Marks M; Hunt SP; Stanford SC; Lydall GJ; Morgan MY; Asherson P; Curtis D; Gurling HM
    Am J Med Genet B Neuropsychiatr Genet; 2014 Jun; 165B(4):373-80. PubMed ID: 24817687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiotensin converting enzyme inhibitor, captopril, prevents the hyperactivity and impulsivity of neurokinin-1 receptor gene 'knockout' mice: sex differences and implications for the treatment of attention deficit hyperactivity disorder.
    Porter AJ; Pillidge K; Grabowska EM; Stanford SC
    Eur Neuropsychopharmacol; 2015 Apr; 25(4):512-21. PubMed ID: 25703442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NK1R-/- mouse phenotype suggests that small body size, with a sex- and diet-dependent excess in body mass and fat, are physical biomarkers for a human endophenotype with vulnerability to attention deficit hyperactivity disorder.
    Pillidge K; Heal DJ; Stanford SC
    J Psychopharmacol; 2016 Sep; 30(9):848-55. PubMed ID: 27462087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance deficits of NK1 receptor knockout mice in the 5-choice serial reaction-time task: effects of d-amphetamine, stress and time of day.
    Yan TC; Dudley JA; Weir RK; Grabowska EM; Peña-Oliver Y; Ripley TL; Hunt SP; Stephens DN; Stanford SC
    PLoS One; 2011 Mar; 6(3):e17586. PubMed ID: 21408181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lack of functional NK1 receptors explains most, but not all, abnormal behaviours of NK1R-/- mice(1).
    Porter AJ; Pillidge K; Tsai YC; Dudley JA; Hunt SP; Peirson SN; Brown LA; Stanford SC
    Genes Brain Behav; 2015 Feb; 14(2):189-99. PubMed ID: 25558794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the performance of NK1R-/- ('knockout') and wildtype mice in the 5‑Choice Continuous Performance Test.
    Porter AJ; Pillidge K; Stanford SC; Young JW
    Behav Brain Res; 2016 Feb; 298(Pt B):268-77. PubMed ID: 26522842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raised arterial blood pressure in neurokinin-1 receptor-deficient mice (NK1R(-/-) ): evidence for a neural rather than a vascular mechanism.
    Moyes AJ; Stanford SC; Hosford PS; Hobbs AJ; Ramage AG
    Exp Physiol; 2016 May; 101(5):588-98. PubMed ID: 26876733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of L-type Ca(v) channels with nifedipine differentially affects performance of wildtype and NK1R-/- mice in the 5-Choice Serial Reaction-Time Task.
    Dudley JA; Weir RK; Yan TC; Grabowska EM; Grimmé AJ; Amini S; Stephens DN; Hunt SP; Stanford SC
    Neuropharmacology; 2013 Jan; 64():329-36. PubMed ID: 22884624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats.
    Rowley HL; Kulkarni RS; Gosden J; Brammer RJ; Hackett D; Heal DJ
    J Psychopharmacol; 2014 Mar; 28(3):254-69. PubMed ID: 24327450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention-deficit/hyperactivity phenotype in mice lacking the cyclin-dependent kinase 5 cofactor p35.
    Drerup JM; Hayashi K; Cui H; Mettlach GL; Long MA; Marvin M; Sun X; Goldberg MS; Lutter M; Bibb JA
    Biol Psychiatry; 2010 Dec; 68(12):1163-71. PubMed ID: 20832057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacr1 gene variation and neurokinin 1 receptor expression is associated with antagonist efficacy in genetically selected alcohol-preferring rats.
    Schank JR; Tapocik JD; Barbier E; Damadzic R; Eskay RL; Sun H; Rowe KE; King CE; Yao M; Flanigan ME; Solomon MG; Karlsson C; Cheng K; Rice KC; Heilig M
    Biol Psychiatry; 2013 Apr; 73(8):774-81. PubMed ID: 23419547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter.
    Takamatsu Y; Hagino Y; Sato A; Takahashi T; Nagasawa SY; Kubo Y; Mizuguchi M; Uhl GR; Sora I; Ikeda K
    Curr Mol Med; 2015; 15(3):245-52. PubMed ID: 25817856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The behavioural response of mice lacking NK₁ receptors to guanfacine resembles its clinical profile in treatment of ADHD.
    Pillidge K; Porter AJ; Dudley JA; Tsai YC; Heal DJ; Stanford SC
    Br J Pharmacol; 2014 Oct; 171(20):4785-96. PubMed ID: 25074741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice.
    Beaulieu JM; Sotnikova TD; Gainetdinov RR; Caron MG
    J Biol Chem; 2006 Oct; 281(43):32072-80. PubMed ID: 16954211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
    Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
    Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant regulation of synchronous network activity by the attention-deficit/hyperactivity disorder-associated human dopamine D4 receptor variant D4.7 in the prefrontal cortex.
    Zhong P; Liu W; Yan Z
    J Physiol; 2016 Jan; 594(1):135-47. PubMed ID: 26541360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomoxetine reduces hyperactive/impulsive behaviours in neurokinin-1 receptor 'knockout' mice.
    Pillidge K; Porter AJ; Vasili T; Heal DJ; Stanford SC
    Pharmacol Biochem Behav; 2014 Dec; 127():56-61. PubMed ID: 25450119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.